In human pancreatic tumors, K-ras mutations occur at the earliest stages of PanIN development, while loss of commonly mutated tumor suppressor genes, such as p53 and INK4a occurs later in the PanIN-PDAC lineage [7]. The gene discussed is CDKN2A; the disease is pancreatic neoplasm.